Health-related quality of life with belzutifan versus everolimus for advanced kidney cancer
People with kidney cancer have been shown to have changes (mutations) in [...]
People with kidney cancer have been shown to have changes (mutations) in [...]
The KEYMAKER-U03 study is looking at different combinations of immunotherapy [...]
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for [...]
Updated results from the phase 2 LITESPARK-003 trial with belzutifan [...]
We are delighted to announce that the National Institute for [...]
People with kidney cancer have been shown to have changes (mutations) in [...]
People with kidney cancer have been shown to have changes [...]
The Food and Drug Administration (FDA) in the United States [...]
Studies looking at the genes of people with kidney cancer have shown [...]
Treatments for people with metastatic kidney cancer have changed over [...]